This report contains market size and forecasts of PD1&PDL1 Inhibitors in global, including the following market information:
Global PD1&PDL1 Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global PD1&PDL1 Inhibitors Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five PD1&PDL1 Inhibitors companies in 2021 (%)
The global PD1&PDL1 Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PD1 Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of PD1&PDL1 Inhibitors include Bristol-Myers Squibb, Merck, Roche, Pfizer, AstraZeneca and Ono Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the PD1&PDL1 Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global PD1&PDL1 Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global PD1&PDL1 Inhibitors Market Segment Percentages, by Type, 2021 (%)
PD1 Inhibitors
PDL1 Inhibitors
Global PD1&PDL1 Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global PD1&PDL1 Inhibitors Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global PD1&PDL1 Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global PD1&PDL1 Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies PD1&PDL1 Inhibitors revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies PD1&PDL1 Inhibitors revenues share in global market, 2021 (%)
Key companies PD1&PDL1 Inhibitors sales in global market, 2017-2022 (Estimated), (K Units)
Key companies PD1&PDL1 Inhibitors sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol-Myers Squibb
Merck
Roche
Pfizer
AstraZeneca
Ono Pharmaceutical